Measures Of Aortic Stenosis Severity Research Articles

Aortic stenosis assessment from the 3-chamber cine: Ratio of balanced steady-state-free-precession (bSSFP) blood signal between the aorta and left ventricle predicts severity

BackgroundCardiovascular magnetic resonance (CMR) imaging is an important tool for evaluating the severity of aortic stenosis (AS), co-existing aortic disease, and concurrent myocardial abnormalities. Acquiring this additional information requires protocol adaptations and additional scanner time, but is not necessary for the majority of patients who do not have AS. We observed that the relative signal intensity of blood in the ascending aorta on a balanced steady state free precession (bSSFP) 3-chamber cine was often reduced in those with significant aortic stenosis. We investigated whether this effect could be quantified and used to predict AS severity in comparison to existing gold-standard measurements. MethodsMulti-centre, multi-vendor retrospective analysis of patients with AS undergoing CMR and transthoracic echocardiography (TTE). Blood signal intensity was measured in a ∼1 cm2 region of interest (ROI) in the aorta and left ventricle (LV) in the 3-chamber bSSFP cine. Because signal intensity varied across patients and scanner vendors, a ratio of the mean signal intensity in the aorta ROI to the LV ROI (Ao:LV) was used. This ratio was compared using Pearson correlations against TTE parameters of AS severity: aortic valve peak velocity, mean pressure gradient and the dimensionless index. The study also assessed whether field strength (1.5 T vs. 3 T) and patient characteristics (presence of bicuspid aortic valves (BAV), dilated aortic root and low flow states) altered this signal relationship. Results314 patients (median age 69 [IQR 57–77], 64% male) who had undergone both CMR and TTE were studied; 84 had severe AS, 78 had moderate AS, 66 had mild AS and 86 without AS were studied as a comparator group. The median time between CMR and TTE was 12 weeks (IQR 4–26). The Ao:LV ratio at 1.5 T strongly correlated with peak velocity (r = −0.796, p = 0.001), peak gradient (r = −0.772, p = 0.001) and dimensionless index (r = 0.743, p = 0.001). An Ao:LV ratio of < 0.86 was 84% sensitive and 82% specific for detecting AS of any severity and a ratio of 0.58 was 83% sensitive and 92% specific for severe AS. The ability of Ao:LV ratio to predict AS severity remained for patients with bicuspid aortic valves, dilated aortic root or low indexed stroke volume. The relationship between Ao:LV ratio and AS severity was weaker at 3 T. ConclusionsThe Ao:LV ratio, derived from bSSFP 3-chamber cine images, shows a good correlation with existing measures of AS severity. It demonstrates utility at 1.5 T and offers an easily calculable metric that can be used at the time of scanning or automated to identify on an adaptive basis which patients benefit from dedicated imaging to assess which patients should have additional sequences to assess AS.

Reproducibility of Echocardiographic Measures of Aortic Stenosis Severity and its Impact on Grading of Severity

Reproducibility of Echocardiographic Measures of Aortic Stenosis Severity and its Impact on Grading of Severity

Impact of transcatheter aortic valve implantation on circulating von Willebrand factor in patients with severe aortic stenosis.

Severe aortic stenosis (AS) can lead to degradation of high molecular weight (HMW) von Willebrand factor (VWF) which can result in haemostatic abnormalities. While studies have explored changes in VWF profiles before and after surgical aortic valve replacement (SAVR), the longer-term changes in VWF profiles pre- and post-transcatheter aortic valve implantation (TAVI) are less understood. Our primary objective was to identify differences in VWF multimer profiles and VWF function pre-TAVI and 1-month post-TAVI. Our secondary objective was to correlate VWF markers with measures of AS severity. Adult patients with severe AS referred for TAVI at our institution were prospectively enrolled in this cohort study. Blood samples were collected for plasma analysis at three time points for all patients: 1day pre-TAVI, 3days post-TAVI, and 1-month post-TAVI. VWF antigen, activity, propeptide, collagen binding, multimers, and factor VIII coagulant activity were determined at each time point. Correlations between VWF parameters and severity of AS were assessed. Twenty participants (15 males, five females) with severe AS were recruited for the study. There was a significant increase in HMW VWF between pre-procedure and 1-month post-TAVI (p<.05). There was a transient increase in VWF antigen levels and activity at 3-days post TAVI that decreased to pre-TAVI levels at 1-month. There were no statistically significant correlations between VWF markers and AS severity. This is the first study to elucidate longer-term (>1week) improvements in HMW VWF after a TAVI procedure in severe AS patients.

Extracellular volume is an independent predictor of peak cardiac power in asymptomatic patients with moderate-to-severe aortic stenosis

Abstract Funding Acknowledgements Type of funding sources: Other. Main funding source(s): The PRIMID study was funded by an NIHR fellowship (Post-Doctoral Fellowship supported by the National Institute for Health Research (NIHR-PDF 2011–04–51 Gerald P McCann.) Background Cardiac power (CP) describes the cardiac work done to maintain arterial pressure in the vasculature and peak CP is the ceiling of pumping performance the heart can achieve. Mean pressure gradient adjusted CP (MPG-CP) gives a more accurate representation of afterload in patients with aortic stenosis (AS) but its association with left-ventricular remodelling parameters is unknown. Purpose To establish the determinants of peak MPG-CP in asymptomatic patients with AS. Methods In this prospective, multi-centre observational study, asymptomatic patients with moderate to severe AS underwent echocardiography, cardiovascular magnetic resonance (CMR) imaging and cardiopulmonary exercise testing. Peak MPG-CP was calculated at peak exercise during an incremental symptom-limited exercise test on semi-supine ergometer, using the formula shown (Figure-1). Clinical and imaging univariable and multivariable associations of peak MPG-CP were assessed by linear regression. Results Peak MPG-CP was measured in 86 patients (mean age 66±12 years, 77% male, mean aortic valve area (AVA) 1.08±0.33 cm^2). On univariable analysis, peak MPG-CP was directly correlated with echocardiogram-measured AVA, peak pressure gradient, max velocity, and CMR-measured myocardial perfusion reserve (MPR), LV mass index (LVMI) and LV end-diastolic volume index (LVEDVI), and inversely correlated with extracellular volume (ECV) and NT-proBNP (Table-1). ECV was the only variable independently associated with peak MPG-CP regardless of which measure of AS severity was inputted in the multivariable model. Conclusions ECV, a marker of diffuse interstitial fibrosis, is an independent predictor of peak MPG-CP in asymptomatic patients with moderate-severe AS. Given ECV's role as a prognosticator, CP parameters may be important markers of subclinical disease and serve as surrogates for fibrotic burden and risk-stratification tools in asymptomatic AS.

Underestimation of Aortic Stenosis Severity by Doppler Mean Gradient during Atrial Fibrillation: Insights from Aortic Valve Weight

Doppler mean gradient (MG) can underestimate aortic stenosis (AS) severity when obtained during atrial fibrillation (AF) compared with sinus rhythm (SR). Aortic valve weight (AVW) is a flow-independent measure of AS severity. The objective of this study was to determine whether AVW or AVW/MG ratio was increased in AF versus SR in patients with AS. Excised native aortic valves from 495 consecutive patients (median age, 77years; interquartile range [IQR], 71-82years; 40% women), with left ventricular ejection fractions ≥50% who underwent surgical aortic valve replacement for native valve severe AS (aortic valve area ≤ 1cm2 or indexed aortic valve area ≤ 0.6cm2/m2) were weighed. Excised AVW/MG ratios were compared in AF versus SR in patients with high-gradient AS (aortic peak velocity ≥ 4m/sec or MG≥40mm Hg) and low-gradient AS (aortic peak velocity < 4m/sec and MG<40mm Hg) in sex-specific analyses. AF was present in 51 patients (10%; 11 of 51 [22%] had low-gradient AS) and SR in 444 (90%; 23 of 444 [5%] had low-gradient AS). There was no difference in sex distribution between AF and SR. Aortic valve area was not different, but forward stroke volume index and transaortic valve flow rate were lower in AF (P≤.002 for all); MG was lower in AF versus SR (median, 46mm Hg [IQR, 37-50mm Hg] vs 50mm Hg [IQR, 44-61mm Hg]; P<.0001). Overall AVW was not different (median, 2,290mg [IQR, 1,830-3,063mg] vs 2,140mg [IQR, 1,530-2,958mg]; P=.31), but overall AVW/MG ratio was higher in AF (median, 55 [IQR, 41-67] vs 42 [IQR, 30-55]; P=.001). In sex- and MG-specific analyses, the AVW/MG ratio was higher in AF compared with SR in men with high-gradient AS (median, 58 [IQR, 41-75] vs 51 [IQR, 39-61]; P=.03), but the differences were not statistically significant between AF and SR in other groups. AVW was discordant to Doppler MG in AF compared with SR in men with high-gradient AS. Additional studies of the relationship of MG to other measures of AS severity, such as leaflet fibrosis, are needed.

Ejection dynamics in native aortic valve stenosis using echocardiography: can it be helpful?

Abstract Background The assessment of aortic stenosis (AS) severity has a major impact on the management of affected patients. Ejection dynamics, including acceleration time (AT), ejection time (ET), and acceleration time/ejection time ratio (AT/ET) measured using doppler echocardiography are established in the evaluation of prosthetic aortic valve stenosis with high sensitivity and specificity. However, their clinical utility in native AS has not been well described. Purpose The aim of this systematic review was to evaluate the diagnostic accuracy of ejection dynamics to identify severe AS and to assess whether ejection dynamics can differentiate low flow, low gradient severe AS from pseudo-severe AS. Methods We conducted a systematic review of Medline, Embase, and Web of Science from database inception until January 2021. We included observational studies and randomized controlled trials (RCTs) in which the diagnostic accuracy of ejection dynamics by doppler echocardiography for severe AS was compared with standard echocardiographic diagnostic criteria including peak velocity, mean pressure gradient, aortic valve area, and dimensionless index. Studies were eligible if they included AS of at least mild severity. Two authors independently screened and extracted data. Results We included 12 studies in the review (RCT=1, observational=11) with a total of 5182 participants. There was significant inconsistency in outcome measurement and reporting of results therefore a meta-analysis was not suitable. We used narrative synthesis to report our results. All included studies used standard echocardiographic criteria to ascertain the presence of severe AS. Mean age was 72 years and 53% of the participants were male. 1983 participants (38.3%) were classified as having severe AS. AT &amp;gt;94–109ms had sensitivity of 74–92% and specificity of 72–89% at identifying severe AS. AT/ET &amp;gt;0.34–0.35 showed sensitivity of 67–77% and specificity of 68–100%. Only one study compared low-flow, low-gradient AS with pseudo-severe AS, showing that an AT &amp;gt;100ms had sensitivity 62%, specificity 76%; and AT/ET &amp;gt;0.33, sensitivity 65%, specificity 84%. Data for ET showed insufficient consistency and diagnostic accuracy. Conclusions AT and AT/ET may be useful to corroborate the presence of severe AS. However, more research is needed to understand whether these parameters add incremental prognostic value to standard echocardiographic measures of AS severity. Funding Acknowledgement Type of funding sources: None. Summary of evidence search and selection

Association between multimodality measures of aortic stenosis severity and quality-of-life improvement outcomes after transcatheter aortic valve replacement.

Up to 40% of patients with aortic stenosis (AS) present with discordant grading of AS severity based on common transthoracic echocardiography (TTE) measures. Our aim was to evaluate the utility of TTE and multi-detector computed tomography (MDCT) measures in predicting symptomatic improvement in patients with AS undergoing transcatheter aortic valve replacement (TAVR). A retrospective review of 201 TAVR patients from January 2017 to November 2018 was performed. Pre- and post-intervention quality-of-life was measured using the Kansas City Cardiomyopathy Questionnaire (KCCQ-12). Pre-intervention measures including dimensionless index (DI), stroke volume index (SVI), mean transaortic gradient, peak transaortic velocity, indexed aortic valve area (AVA), aortic valve calcium score, and AVA based on hybrid MDCT-Doppler calculations were obtained and correlated with change in KCCQ-12 at 30-day follow-up. Among the 201 patients studied, median KCCQ-12 improved from 54.2 pre-intervention to 85.9 post-intervention. In multivariable analysis, patients with a mean gradient >40 mmHg experienced significantly greater improvement in KCCQ-12 at follow-up than those with mean gradient ≤40 mmHg (28.1 vs. 16.4, P = 0.015). Patients with MDCT-Doppler-calculated AVA of ≤1.2 cm2 had greater improvements in KCCQ-12 scores than those with computed tomography-measured AVA of >1.2 cm2 (23.4 vs. 14.1, P = 0.049) on univariate but not multivariable analysis. No association was detected between DI, SVI, peak velocity, calcium score, or AVA index and change in KCCQ-12. Mean transaortic gradient is predictive of improvement in quality-of-life after TAVR. This measure of AS severity may warrant greater relative consideration when selecting the appropriateness of patients for TAVR.

Prognostic value of automated longitudinal strain measurements in asymptomatic aortic stenosis

ObjectiveTwo-dimensional (2D) longitudinal strain (LS) predicts cardiac events in aortic stenosis (AS). However, it requires manual editing, which affects its accuracy and reliability. We investigated whether left ventricular (LV), left...

The Association between Aortic Valve Weight, Echocardiographic Indices, and All-Cause Death in 1,046 Patients Undergoing Surgical Aortic Valve Replacement for Aortic Stenosis

Background: Aortic valve weight (AVW), a flow independent measure of aortic stenosis (AS) severity, is reported to have heterogeneous associations with the echocardiographic variables used for AS evaluation. Controversy exists regarding its impact on survival after aortic valve replacement (AVR). Objective: We sought to determine the association between AVW with echocardiographic measures of AS severity and all-cause mortality after surgical AVR. Methods: One thousand and forty-sixconsecutive patients underwent surgical AVR for AS, the excised valves were weighed, and an echocardiogram was done before surgery. Results: Males had heavier valves than females, for both absolute and body surface are (BSA)-indexed values (2.78 ± 1.23 vs. 2.08 ± 0.68 g, p < 0.001; and 1.38 ± 0.61 vs. 1.19 ± 0.41 g/m², p < 0.001, respectively). In a restricted cohort of 634 patients with isolated severe AS and normal ejection fraction, the correlations of AVW with echocardiographic variables of AS were modest, the strongest being with the dimensionless index (r = –0.27 and –0.26 for male and female, both p < 0.01). Stratified by stroke volume index and mean gradient (MG), no associations were found in the low-gradient groups (i.e., MG <40 mmHg). At a median follow-up of 3.5 years, there were only 244 deaths in the entire cohort. Mortality was not related to AVW, except in females who displayed an inverse relationship (HR = 0.67; 95% CI 0.47–0.95) only when it was analyzed as a continuous variable. Conclusions: The weak correlation between AVW with the echocardiographic indices of AS may reflect its complex pathophysiology, heterogeneous hemodynamics, and possible pitfalls in the current echocardiographic methods used in clinical practice. The prognostic value of AVW after AVR warrants further evaluation.

Heartbeat: Time to switch from aortic valve area to aortic valve index?

Many patients with severe symptomatic aortic stenosis (AS) present for medical care late in the disease course, at a time point when outcomes after surgical or transcatheter aortic valve replacement may not be optimal. The diagnosis of AS is often missed on physical examination by primary care providers.1 Even when an echocardiogram is obtained, discrepancies in measures of AS severity can lead to confusion and failure to refer patients for appropriate intervention. In an effort to use a systems-based approach to improving diagnosis of severe AS, Bradley and colleagues looked at the accuracy of echocardiographic measures of AS severity in over 77 thousand patients over a 4 year period in a single US-based healthcare organisation.2 A combined assessment, using peak velocity, mean gradient, and the dimensionless index (simpler surrogate for aortic valve area [AVA}), provided the best sensitivity (92%) and specificity (99%) for diagnosis of severe AS compared with any single measure alone. (figure 1) Figure 1 Schematic of echocardiographic measures of aortic stenosis as the measurement of left ventricular outflow tract (LVOT) diameter is squared in the …

Predicting Outcomes in Patients With AsymptomaticModerate to Severe Aortic Stenosis

Outcomes in asymptomatic patients with aortic stenosis (AS) have been reported primarily from tertiary centers. Whether observations from a community hospital cohort would be similar or if clinical variables would assume a more important role remains uncertain. This retrospective cohort study from one community hospital followed asymptomatic patients with moderate to severe AS for 3years following an index echocardiogram. Patients underwent standard echocardiographic imaging and assessment of AS severity. Outcomes included aortic valve replacement, onset of Class 4 heart failure and cardiovascular death. Inclusion or exclusion criteria were met by 190 patients (body mass index of 30.8 ± 7.5 kg/m2 and age 70.9 ± 13.0 years). In this obese and racially diverse cohort, adverse outcomes occurred in 72 of 190 (38%), aortic valve replacement in 33 of 72 (46%), heart failure in 30 of 72 (42%), and cardiovascular death in 9 of 72 (13%). Univariate analyses found that the echocardiographic variables assessing AS severity (Vmax, mean aortic valve gradient, and the dimensionless index) were strongly associated with outcomes. A model predicting time to adverse outcomes included age, gender, Charlson index, Vmax, aortic valve area, the electrocardiographic variables of atrial fibrillation and left ventricular strain, and echocardiographic variables unrelated to the direct measurements of stenosis severity. In conclusion, direct echocardiographic measures of AS severity, echocardiographic parameters unrelated to AS severity plus the electrocardiographic variables of atrial fibrillation and left ventricular strain were the dominant predictors of adverse outcomes in a community hospital cohort of asymptomatic patients with moderate to severe AS.

Symptom Onset in Aortic Stenosis: Relation to Sex Differences in Left Ventricular Remodeling

ObjectivesThe aim of this study was to establish sex differences in remodeling and outcome in aortic stenosis (AS) and their associations with biomarkers of myocardial fibrosis. BackgroundThe remodeling response and timing of symptoms is highly variable in AS, and sex plays an important role. MethodsA total of 174 patients (133 men, mean age 66.2 ± 13.3 years) with asymptomatic moderate to severe AS underwent comprehensive stress cardiac magnetic resonance imaging, transthoracic echocardiography, and biomarker analysis (matrix metalloproteinase [MMP]-2, -3, -7, -8, and -9; tissue inhibitor matrix metalloproteinases-1 and -4; syndecan-1 and -4; and N-terminal pro–B-type natriuretic peptide), and were followed up at 6-month intervals. A primary endpoint was a composite of typical AS symptoms necessitating referral for aortic valve replacement, cardiovascular death, or major adverse cardiovascular events. ResultsFor a similar severity of AS, male patients demonstrated higher indexed left ventricular (LV) volumes and mass, more concentric remodeling (higher LV mass/volume), a trend to more late gadolinium enhancement (present in 51.1% men vs. 34.1% women; p = 0.057), and higher extracellular volume index than female patients (13.27 [interquartile range (IQR): 11.5 to 17.0] vs. 11.53 [IQR: 10.5 to 13.5] ml/m2, p = 0.017), with worse systolic and diastolic function and higher MMP-3 and syndecan-4 levels, whereas female patients had higher septal E/e′. Male sex was independently associated with indexed LV mass (β = 13.32 [IQR: 9.59 to 17.05]; p < 0.001). During median follow-up of 374 (IQR: 351 to 498) days, a primary outcome, driven by spontaneous symptom onset, occurred in 21.8% of male and 43.9% of female patients (relative risk: 0.50 [95% confidence interval: 0.31 to 0.80]; p = 0.004). Measures of AS severity were associated with the primary outcome in both sexes, whereas N-terminal pro–B-type natriuretic peptide, MMP-3, and mass/volume were only associated in men. ConclusionsIn AS, women tolerate pressure overload with less concentric remodeling and myocardial fibrosis but are more likely to develop symptoms. This may be related to higher wall stress and filling pressures in women.

Symptoms in Patients With Severe Aortic Stenosis and Preserved Left Ventricular Ejection Fraction: Is It All About Diastole?

Although it has been ≈50 years since Ross and Braunwald1 reported the malignant natural history of aortic stenosis (AS) after the onset of angina, syncope, or heart failure, the pathophysiologic underpinnings of these classic symptoms remain incompletely delineated. We appreciate that angina may occur in the absence of epicardial coronary disease with both increased demand and impaired supply, contributing to imbalance of the supply–demand relationship. Exertional syncope reflecting the inability to maintain cerebral perfusion is attributed to an inability to increase cardiac output in combination with, at times, paradoxically reduced systemic vascular resistance. Although we attribute the low-output symptoms of heart failure to the same inability to increase cardiac output, we still have an incomplete understanding of the changes that restrict stroke volume augmentation. Similarly, although the dyspnea of heart failure is typically linked to elevated pulmonary capillary pressures, which of the multiple pathways leading to elevated pulmonary pressures is/are operative in the symptomatic patient with AS? Although afterload mismatch and attendant left ventricular (LV) systolic dysfunction provide a substrate for symptoms in some patients, understanding the basis for symptoms in patients with preserved LV ejection fraction (EF) is particularly challenging because measures of AS severity alone predict the onset of but correlate imperfectly with the presence of symptoms.2 Article see p 142 In this issue of Circulation: Cardiovascular Imaging , Dahl et al3 provide hypothesis-generating data that argue an important role for LV remodeling and diastolic dysfunction in the pathogenesis of symptoms in patients AS and preserved (≥50%) LVEF. They compared echocardiographic parameters in 139 asymptomatic patients assessed in an outpatient clinic and 99 symptomatic patients referred for surgical intervention. Although the symptomatic patients were surprisingly younger, had less atrial fibrillation, hypertension, and chronic lung disease than did the asymptomatic cohort, higher LV mass index and …

Energy Loss Index in Aortic Stenosis

In the American Heart Association–American College of Cardiology and European Society of Cardiology–European Association for Cardio-Thoracic Surgery guidelines,1,2 aortic valve replacement (AVR) is considered a class I indication in patients with aortic stenosis (AS) if the stenosis is severe and the patient has symptoms or left ventricular ejection fraction <50%. Hence, accurate assessment of the hemodynamic severity of the valvular stenosis is crucial for clinical decision making. The stenosis severity is generally determined by measuring the transvalvular pressure gradient or the aortic valve effective orifice area (AVA); however, these conventional parameters do not account for the extent of pressure recovery that may occur downstream of the stenosis. In an article published in 2000 in Circulation ,3 we proposed a new Doppler echocardiographic parameter based on the energy loss concept to adjust the AVA for pressure recovery, and we postulated that this energy loss index (ELI) would improve assessment of stenosis severity and risk stratification in AS. Thirteen years later, Bahlmann and colleagues4 publish in this issue of Circulation the first prospective study to demonstrate that ELI provides independent and incremental prognostic information to that derived from conventional measures of AS severity. In this elegant substudy of the SEAS (Simvastatin Ezetimibe in Aortic Stenosis) trial, the authors report that a 1 cm2/m2 reduction in baseline ELI predicts a 2-fold increase in the risk of aortic valve events and of the composite of mortality and heart failure hospitalization after adjustment for peak aortic jet velocity or mean gradient. Article see p 1149 The current guidelines1,2 make no distinction between catheterization and Doppler echocardiographic measurements, as though values for gradient and AVA measured by either technique were interchangeable (Figure 1). Yet Doppler estimates the maximum pressure drop through the valve from the …

Prognostic Value of Energy Loss Index in Asymptomatic Aortic Stenosis

Aortic valve area index adjusted for pressure recovery (energy loss index [ELI]) has been suggested as a more accurate measure of aortic stenosis (AS) severity, but its prognostic value has not been determined in a prospective study. The relation between baseline ELI and rate of aortic valve events and combined total mortality and hospitalization for heart failure resulting from the progression of AS was assessed by multivariate Cox regression and reclassification analysis in 1563 patients with initial asymptomatic AS in the Simvastatin and Ezetimibe in Aortic Stenosis (SEAS) study. During 4.3 years follow-up, a total of 498 aortic valve events and 181 combined total mortalities and hospitalizations for heart failure caused by the progression of AS occurred. In Cox regression analyses, 1-cm(2)/m(2) lower baseline ELI predicted a 2-fold higher risk both for aortic valve events and for combined total mortality and hospitalization for heart failure independently of baseline peak aortic jet velocity or mean aortic gradient and independently of aortic root size (all P<0.05). In reclassification analysis, ELI improved the prediction of aortic valve events by 13% (95% confidence interval, 5-19), whereas the prediction of combined total mortality and hospitalization for heart failure resulting from the progression of AS did not improve significantly. In asymptomatic AS patients without known atherosclerotic disease or diabetes mellitus, ELI provides independent and additional prognostic information to that derived from conventional measures of AS severity, suggesting that ELI should be measured in such patients. URL: http://www.clinicaltrials.gov. Unique identifier: NCT00092677.

Alterations in multidirectional myocardial functions in patients with aortic stenosis and preserved ejection fraction: a two-dimensional speckle tracking analysis

To identify changes in multidirectional strain and strain rate (SR) in patients with aortic stenosis (AS). A total of 420 patients (age 66.1 ± 14.5 years, 60.7% men) with aortic sclerosis, mild, moderate, and severe AS with preserved left ventricular (LV) ejection fraction [(EF), ≥50%] were included. Multidirectional strain and SR imaging were performed by two-dimensional speckle tracking. Patients were more likely to be older (P < 0.001) and at a worse New York Heart Association functional class (P < 0.001) with increasing AS severity. There was a progressive stepwise impairment in longitudinal, circumferential, and radial strain and SR with increasing AS severity (all P < 0.001). The myocardial dysfunction appeared to start in the subendocardium with mild AS, to mid-wall dysfunction with moderate AS, and eventually transmural dysfunction with severe AS. Aortic valve area, as a measure of AS severity, was an independent determinant of multidirectional strain and SR on multiple linear regressions. Patients with AS have evidence of subclinical myocardial dysfunction early in the disease process despite normal LVEF. The myocardial dysfunction appeared to start in the subendocardium and progressed to transmural dysfunction with increasing AS severity. Symptomatic moderate and severe AS patients had more impaired multidirectional myocardial functions compared with asymptomatic patients.

Statins and Progression of Calcified Aortic Stenosis

To review the evidence evaluating the efficacy of statins in reducing the progression of calcified aortic stenosis (AS). MEDLINE, EMBASE, and PubMed were searched (all up to November 2006) for studies evaluating the use of statins to reduce the progression of calcified AS. Search terms included statin, HMG CoA reductase inhibitor, calcified AS, valve stenosis, and calcified stenosis. Additional primary trials were located by searching references noted in review articles. Clinical trials published in the English language were selected for review. Primary efficacy outcomes evaluated were changes in aortic valve measurements, hemodynamic measures of AS, and change in measures of AS severity. Two prospective clinical trials and 5 retrospective studies were included in this review. All of the retrospective studies demonstrated that statin use was associated with a statistically significant delay in the progression of AS. One prospective observation trial showed benefit of statin use; however, a large, randomized, double-blind, prospective trial showed no benefit of statin use in decreasing the progression of AS. An association between statin use and a delay in AS progression has been observed in retrospective studies; however, prospective trials showed conflicting results. Currently, statins cannot be recommended for medical treatment of AS until larger trials are conducted.

Evaluation and Management of Patients With Aortic Stenosis

Case presentation: A 66-year-old man is referred to a cardiologist for the evaluation of a heart murmur. The patient claims to be entirely asymptomatic, although his wife notes that he has decreased his physical activity over the past two years because he is “getting old.” At physical examination, his blood pressure was 120/70 mm Hg; pulse, 80 bpm; respiration, 13 breaths per minute; and temperature, 99.0°F. Cardiovascular examination revealed normal central venous pressure. His carotid upstrokes were reduced in volume and delayed in upstroke. Cardiac examination revealed a forceful sustained apical impulse in its normal position. There was a 3/6 late-peaking systolic ejection murmur heard at the right upper sternal border radiating to the neck. The rest of the physical examination was unremarkable. Echo-Doppler evaluation revealed an ejection fraction of 0.60, a left ventricular free wall thickness of 1.3 cm, and a peak transaortic flow velocity of 4.5 m/s. How should this patient be managed? Should he undergo aortic valve replacement now? Should he undergo longitudinal follow-up to monitor progression of his aortic stenosis? Over the past 40 years, diagnostic techniques, substitute cardiac valves, and valve implantation surgery have undergone continued improvement, reducing the risk of the valve replacement and enhancing its benefits. Thus, the risk-benefit analysis of valve surgery has tilted in favor of increasingly early intervention for valve disease. The following is a summary incorporating this concept into the current strategy for managing patients with aortic stenosis such as the one described above. The patient with severe aortic stenosis who presents with symptoms represents the most straightforward management strategy for the disease. Survival is nearly normal until the classic symptoms of angina, syncope, or dyspnea develop.1 However, only 50% of patients who present with angina survive 5 years, whereas 50% survival is 3 years for patients who …

Aortic valve calcium measured by electron beam computed tomography: a potential new measure of aortic stenosis severity

Aortic valve calcium measured by electron beam computed tomography: a potential new measure of aortic stenosis severity

Flow Dependence of Measures of Aortic Stenosis Severity During Exercise

Flow Dependence of Measures of Aortic Stenosis Severity During Exercise